EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial

Narendra Vaidya, Ramshyam Agarwal, D G Dipankar, Hrishikesh Patkar, Gayatri Ganu, Dheeraj Nagore, Chhaya Godse, Anirudh Mehta, Dilip Mehta, Sujit Nair

Pharmaceutical Research · 2025

DOI: 10.1007/s11095-025-03818-2 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pharmaceutical Research, 2025. Verfasst von Narendra Vaidya und 9 weiteren Autor:innen. Beteiligte Einrichtung: Lokmanya Medical Research Center and Hospital, Pune, 411033, India. Hauptthemen laut MEDLINE: Boswellia, Osteoarthritis, Knee, Plant Extracts. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Phytoveda Pvt. Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteoarthritis is the prevailing form of inflammatory condition in joints of adults and the aging population, leading to long-term disability and chronic pain. Current therapeutic options have variable therapeutic efficacy and/or several side effects.

Methods

A randomized, placebo-controlled, double-blind clinical trial was conducted in 62 participants using a nutraceutical [standardized Boswellia serrata Roxb. gum resin (300 mg) and Apium graveolens L. seed extract (250 mg)], to determine its safety and efficacy for supporting cartilage health and reduction in knee osteoarthritis symptoms. All participants were assessed for physical function and pain with the help of WOMAC, VAS, Physicians' Global Assessment for the six-minute walk test/pain. Knee X-ray, KOOS questionnaire score, and FACIT-F score were assessed. Additionally, inflammatory, cartilage degeneration and regeneration biomarkers in serum and urine were evaluated at baseline and after 90 days of treatment.

Results

Oral administration of the nutraceutical resulted in prolonged symptomatic relief with reduced pain, stiffness, and swelling. Inflammatory (serum IL-7, IL-1, IL-6, hs-CRP, TNF-α, ESR) and cartilage degeneration biomarkers (serum CTX-II, COMP, MMP-3 and urinary CTX-II) were decreased in the nutraceutical group compared to baseline and placebo. Furthermore, serum N-propeptide of collagen IIA (PIIANP) and procollagen-type-C propeptide (PIICP) levels were increased in the nutraceutical group, suggesting collagen synthesis contributing to cartilage regeneration. At given doses for 90 days, there were no adverse effects based on the clinical examination, biochemical, hematological, and ECG analysis.

Conclusions

Taken together, the combination of Boswellia and celery could be a safe and promising herbal nutraceutical option for managing osteoarthritis and cartilage health effectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BoswelliaOsteoarthritis, KneePlant ExtractsHumansDouble-Blind MethodFemaleMaleMiddle AgedAgedDietary SupplementsTreatment OutcomeCartilage, ArticularBiomarkers

Stichwörter der Autor:innen

cartilage supportclinical trialinflammationknee osteoarthritisnutraceutical

Substanzen

Plant ExtractsBiomarkers

Autor:innen und Institutionen

  • Lokmanya Medical Research Center and Hospital, Pune, 411033, India.
  • Dr. D. Y. Patil College of Ayurved & Research Centre, Pimpri-Chinchwad, 411018, India.
  • Sangvi Multispeciality Hospital Pvt. Ltd, Pune, 411027, India.
  • MPREX Healthcare Pvt. Ltd., Pune, 411057, India.
  • Phytoveda Pvt. Ltd., V.N. Purav Marg, Mumbai, 400022, India.
  • Viridis Biopharma Pvt. Ltd., Mumbai, 400022, India.

Förderung

  • Phytoveda Pvt. Ltd.

Zitieren

APA

Vaidya, N., Agarwal, R., Dipankar, D. G., Patkar, H., Ganu, G., Nagore, D., Godse, C., Mehta, A., Mehta, D., & Nair, S. (2025). Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial. Pharmaceutical Research. https://doi.org/10.1007/s11095-025-03818-2

Vancouver

Vaidya N, Agarwal R, Dipankar DG, Patkar H, Ganu G, Nagore D, et al. Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial. Pharmaceutical Research. 2025. doi:10.1007/s11095-025-03818-2

BibTeX
@article{Vaidya2025,
  author = {Vaidya, Narendra and Agarwal, Ramshyam and Dipankar, D G and Patkar, Hrishikesh and Ganu, Gayatri and Nagore, Dheeraj and Godse, Chhaya and Mehta, Anirudh and Mehta, Dilip and Nair, Sujit},
  title = {Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial},
  journal = {Pharmaceutical Research},
  year = {2025},
  doi = {10.1007/s11095-025-03818-2}
}
Kostenlos starten →